With the recent grant from the Swedish Research Council that enabled BioMS to establish clinical mass spectrometry platforms with identical setups of instrument at each node, there is an increasing need to educate researchers and clinicians in how mass spectrometry can be used to address clinical research questions.
In the Photo: Filip Årman, Lotta Happonen, Johan Malmström och Patrik Önnerfjord.
Patrik Önnerfjord and Lotta Happonen, both at BioMS Lund, initiated a PhD-level course in Clinical Proteomics and Biological Mass Spectrometry, which was organized for the first time in Lund, december 2022.
The course will be arranged on a yearly basis each autumn term.
The course targets both clinicians and experimental researchers mainly at the Medical Faculty at Lund University. The course was attended by both PhD students as well as postdoctoral researchers in varied research areas, and covered basic principles of mass spectrometry and proteomics, separation of proteins and peptides, sample preparation techniques, data acquisition methods as well as data analysis and bioinformatics, the latter part lectured by Filip Årman at BioMS Lund.
Guest speakers within clinical proteomics were invited to show typical applications in the field. The overall response was very positive, and the course clearly targets a gap in knowledge relating to how different mass spectrometry-based proteomics approaches can be used to study diverse biological phenomena.